Jessica Kong

TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease

Melanie Shulman, Jessica Kong, John O’Gorman et al. · Nature Aging · 2023 · 79 citations · Full text

Medicine, Neurology, Pharmacology +16

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis

Nicolas Wisniacki, Lakshmi Amaravadi, Gerald R. Galluppi et al. · Clinical Therapeutics · 2013 · 71 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

An exploration of instructors' and students' perspectives on remote delivery of courses during the COVID‐19 pandemic

Victoria Chen, Adam Sandford, Matthew LaGrone et al. · British Journal of Educational Technology · 2022 · 71 citations · Full text

Education, Educational Technology, Higher Education +17

Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing–remitting multiple sclerosis: findings from the CONFIRM study

Mariko Kita, Robert J. Fox, J. Theodore Phillips et al. · Multiple Sclerosis Journal · 2013 · 49 citations

Pharmacy, Neurology, Pharmacotherapy +15

Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies

Mariko Kita, Robert J. Fox, Ralf Gold et al. · Clinical Therapeutics · 2014 · 40 citations

Pharmacy, Neurology, Pharmacotherapy +11